These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16840880)
1. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. Biederman J; Spencer TJ; Wilens TE; Prince JB; Faraone SV J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1147-1150. PubMed ID: 16840880 [No Abstract] [Full Text] [Related]
2. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death. Knight M Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281 [No Abstract] [Full Text] [Related]
4. [Medication for ADHD and the risk of cardiovascular mortality]. Kalverdijk LJ; Buitelaar JK; van der Gaag RJ Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2283-4; author reply 2284. PubMed ID: 17078147 [No Abstract] [Full Text] [Related]
5. Stimulants and sudden death: what is a physician to do? Wilens TE; Prince JB; Spencer TJ; Biederman J Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018 [TBL] [Abstract][Full Text] [Related]
6. Attention deficit hyperactivity disorder medications in children with heart disease. Berger S Curr Opin Pediatr; 2016 Oct; 28(5):607-12. PubMed ID: 27261563 [TBL] [Abstract][Full Text] [Related]
7. [Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions]. Banaschewski T; Z Kinder Jugendpsychiatr Psychother; 2008 Nov; 36(6):437-9. PubMed ID: 19034859 [No Abstract] [Full Text] [Related]
8. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate]. Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201 [TBL] [Abstract][Full Text] [Related]
9. ECGs before stimulants in children. Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112 [No Abstract] [Full Text] [Related]
10. ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk. Kratochvil CJ Am J Psychiatry; 2012 Feb; 169(2):112-4. PubMed ID: 22318789 [No Abstract] [Full Text] [Related]
11. Encouraging news about ADHD drugs and heart risk in adults. Harv Ment Health Lett; 2012 Mar; 28(9):7. PubMed ID: 22474711 [No Abstract] [Full Text] [Related]
12. Stimulant treatment of ADHD and risk of sudden death in children. Vitiello B; Towbin K Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196 [No Abstract] [Full Text] [Related]
14. The effects of stimulant medications for ADHD. Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389 [No Abstract] [Full Text] [Related]
15. Long-term safety of stimulant medications used to treat children with ADHD. Lerner M; Wigal T Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852 [No Abstract] [Full Text] [Related]
16. Management of a hyperactive teen and cardiac safety. Sowinski H; Karpawich PP Pediatr Clin North Am; 2014 Feb; 61(1):81-90. PubMed ID: 24267459 [TBL] [Abstract][Full Text] [Related]
17. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination? Rohatgi RK; Bos JM; Ackerman MJ Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children. August GJ; Realmuto GM Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573 [No Abstract] [Full Text] [Related]
19. ADHD update: new data on the risks of medication. Harv Ment Health Lett; 2006 Oct; 23(4):3-5. PubMed ID: 17183739 [No Abstract] [Full Text] [Related]
20. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II. Merkel RL Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]